There have been few data on the chemotherapy in elderly advanced non-small cell lung cancer (NSCLC) patients with poor performance status (PS), and usefulness of chemotherapy for such patients remains unclear. The objective of this study was to identify factors that predicted the survival benefit of chemotherapy. | Serum albumin level as a potential marker for deciding chemotherapy or best supportive care in elderly advanced nonsmall cell lung cancer patients with poor performance status
